SOFAR S.p.A.: Clinical Trials

1 trial sponsored by SOFAR S.p.A., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow SOFAR S.p.A.: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy Evaluation of a Commercial Preparation Containing Lactobacillus Casei DG on the Reduction of the Painful Symptoms Related to the Irritable Bowel Syndrome (IBS). A Pilot Clinical Study
Lactobacillus casei DG - Irritable Bowel Syndrome
Phase 4CompletedSOFAR S.p.A.102012-03-012014-12-02

Conditions studied

Irritable Bowel Syndrome (1)

Countries

Italy (1)

Top investigators

Giovanni Monteleone, Professor (1)